Replies to post #301463 on Amarin Corp Plc (AMRN)

[lizzy241]

rosemount, it's plausible that amarin could capture the FDA approved EPA market, if they went AG with vascepa then acquired the license for DS 102 epeleuton, less aggravation with the generics suing them for their patents. I believe margins would be higher with a synthetic FDA approved EPA. It's a consideration given the similar background of the management from Elan i.e. Dr. Lars Ekman, Dr. Climax et al then and now Dr. Bhatt. You never know!!